Press Release: Spectral Announces Third Quarter -3-
Press Release: Spectral Announces Third Quarter -3-
新聞稿：SPECTRUM宣佈第三季度-3-
exercised 1,129,062 677 - (248) - - 429
Warrants
exercised 1,100,000 735 - - (240) - 495
Loss and
comprehensive
loss for the
period - - - - - (6,951) (6,951)
Share-based
compensation - - - 803 - - 803
-------------- ----------- ------ ----------- ------------ -------- ------- -------------
Balance,
September 30,
2020 236,605,745 71,777 7,981 6,738 2,418 (87,562) 1,352
Public
offering - (2) (2 )
Share options
exercised 150,000 95 - (44) - - 51
Loss and
comprehensive
loss for the
period - - - - - (2,147) (2,147 )
Share-based
compensation - - - 77 - - 77
-------------- ----------- ------ ----------- ------------ -------- ------- -------------
Balance,
December 31,
2020 236,755,745 71,870 7,981 6,771 2,418 (89,709) (669 )
-------------- ----------- ------ ----------- ------------ -------- ------- -------------
Balance,
January 1,
2021 236,755,745 71,870 7,981 6,771 2,418 (89,709) (669 )
Bought deal
offering 23,530,000 7,406 - - 1,464 - 8,870
Share options
exercised 143,333 98 - (46) - - 52
Warrants
exercised 7,457,330 4,983 - - (1,627) - 3,356
Warrants
expired - - 4 - (4) - -
Loss and
comprehensive
loss for the
period - - - - - (6,233) (6,233)
Share-based
compensation - - - 1,117 - - 1,117
-------------- ----------- ------ ----- ----- ------ --------- ---------- -------
Balance,
September 30,
2021 267,886,408 84,357 7,985 7,842 2,251 (95,942) 6,493
-------------- ----------- ------ ----- ----- ------ --------- ---------- -------
Spectral Medical Inc.
Condensed Interim Consolidated
Statements of Cash Flows
(unaudited)
-------------------------------------- --------------------------------------
(in thousands of Canadian dollars)
Nine-months ended September 30,
2021 2020
$ $
-------------------------------------- --------------- --------------
Cash flow provided by (used in)
Operating activities
Loss and comprehensive loss for the
period (6,233) (6,951)
Adjustments for:
Depreciation on right-of-use
asset 70 70
Depreciation on property and
equipment 140 140
Amortization of intangible asset 13 13
Interest expense on lease
liability 21 25
Unrealized foreign exchange loss
on cash 42 32
Share-based compensation 1,117 803
Write down of property and
equipment to fair value 174 -
Gain on disposal of property and
equipment (40) (8)
Changes in items of working capital:
Trade and other receivables (307) (59)
Inventories (51) (67)
Prepayments and other assets (403) (257)
Contract asset - 519
Trade and other payables (806) 776
Contract liabilities (449) 6,183
Net cash (used in) provided by
operating activities (6,712) 1,219
Investing activities
Proceeds on disposal of property and
equipment 77 10
Property and equipment expenditures (401) (215)
Net cash used in investing activities (324) (205)
Financing activities
Proceeds from financing 10,000 5,100
Transaction costs paid (1,130) (784)
Warrants exercised 3,356 495
Share options exercised 52 429
Lease liability payments (84) (81)
Net cash provided by financing
activities 12,194 5,159
Increase in cash 5,158 6,173
Effects of exchange rate changes on
cash (42) (32)
Cash, beginning of period 5,807 1,435
-------------------------------------- --------------- --------------
Cash, end of period 10,923 7,576
-------------------------------------- --------------- -----
鍛鍊1,129,062 677-(248)-429認股權證鍛鍊1,100,000 735--(240)-495損失和全面損失的原因是期間-(6951)(6951)基於共享的薪酬-803--803-------------- ----------- ------ ----------- ------------ -------- ------- ------------- 平衡，9月30日， 2020 236,605,745 71,777 7,981 6,738 2,418 (87,562) 1,352 公眾報價-(2)(2)股票期權鍛鍊150,000 95-(44)--51損失和全面損失的原因是期間-(2,147)(2,147)基於共享的補償-77--77-------------- ----------- ------ ----------- ------------ -------- ------- ------------- 平衡，十二月三十一日， 2020 236,755,745 71,870 7,981 6,771 2,418 (89,709) (669 ) -------------- ----------- ------ ----------- ------------ -------- ------- ------------- 平衡，1月1日， 2021 236,755,745 71,870 7,981 6,771 2,418 (89,709) (669 ) 購買的交易報價23,530,000 7,406--1,464-8,870股票期權練習143,333 98-(46)--52認股權證鍛鍊7,457,330 4,983--(1,627)-3,356認股權證過期--4-(4)--損失和全面損失的原因是期間-(6,233)(6,233)基於共享的薪酬-1,117--1,117-------------- ----------- ------ ----- ----- ------ --------- ---------- ------- 平衡，9月30日， 2021 267,886,408 84,357 7,985 7,842 2,251 (95,942) 6,493 -------------- ----------- ------ ----- ----- ------ --------- ---------- ------- 斯派克醫療公司。壓縮臨時合併現金流量表(未經審計)-------------------------------------- -------------------------------------- (單位：千加元)截至9月30日的9個月， 2021 2020 $ $ -------------------------------------- --------------- -------------- 現金流由(用於)提供經營活動公司的損失和綜合損失期間(6,233)(6,951)對以下各項進行調整：使用權折舊資產70 70物業折舊及設備140 140無形資產攤銷13 13租賃利息支出法律責任21 25未實現匯兑損失現金42 32基於股份的薪酬1117803減記財產及設備公允價值174-處置財產的收益和設備(40)(8)營運資金項目變動情況：貿易和其他應收款(307)(59)庫存(51)(67)預付款和其他資產(403)(257)合同資產-519貿易和其他應付款(806)776合同責任(449)6183提供的現金淨額(用於)經營活動(6712)1219投資活動處置財產所得收益及設備77 10財產和設備支出(401)(215)用於投資活動的現金淨額(324)(205)融資活動融資10,000,5100的收益支付的交易成本(1,130)(784)已行使認股權證3,356,495行使購股權52 429租賃責任付款(84)(81)融資提供的淨現金活動12,194 5,159現金增加5158 6173匯率變動對中國經濟的影響現金(42)(32)現金，期初5,807,1435-------------------------------------- --------------- -------------- 現金，期末10,923,576-------------------------------------- --------------- -----
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。